COGENT BIOSCIENCES INC's ticker is COGT and the CUSIP is 19240Q201. A total of 146 filers reported holding COGENT BIOSCIENCES INC in Q4 2023. The put-call ratio across all filers is 1.14 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $78,000 | +500.0% | 9,220 | +395.4% | 0.00% | – |
| Q1 2024 | $13,000 | -91.4% | 1,861 | -92.8% | 0.00% | – |
| Q4 2023 | $152,000 | +32.2% | 25,956 | +120.7% | 0.00% | – |
| Q3 2023 | $115,000 | +74.2% | 11,759 | +108.9% | 0.00% | – |
| Q2 2023 | $66,000 | +69.2% | 5,630 | +56.3% | 0.00% | – |
| Q1 2023 | $39,000 | -53.6% | 3,603 | -50.3% | 0.00% | – |
| Q4 2022 | $84,000 | +425.0% | 7,245 | +581.6% | 0.00% | – |
| Q3 2022 | $16,000 | +700.0% | 1,063 | +323.5% | 0.00% | – |
| Q2 2022 | $2,000 | -88.2% | 251 | -89.0% | 0.00% | – |
| Q1 2022 | $17,000 | -72.1% | 2,283 | -68.2% | 0.00% | – |
| Q4 2021 | $61,000 | +90.6% | 7,169 | +87.3% | 0.00% | – |
| Q3 2021 | $32,000 | +52.4% | 3,827 | +50.4% | 0.00% | – |
| Q2 2021 | $21,000 | +2000.0% | 2,544 | +1968.3% | 0.00% | – |
| Q4 2020 | $1,000 | – | 123 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 4,884,977 | $52,708,902 | 10.29% |
| COMMODORE CAPITAL LP | 4,772,421 | $51,494,423 | 7.84% |
| TCG Crossover Management, LLC | 3,631,042 | $39,178,943 | 7.64% |
| Fairmount Funds Management LLC | 2,758,975 | $29,769,340 | 5.12% |
| New Leaf Venture Partners, L.L.C. | 501,530 | $5,411,509 | 4.47% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 579,264 | $6,250,259 | 2.58% |
| 5AM Venture Management, LLC | 790,440 | $8,528,848 | 2.18% |
| Ghost Tree Capital, LLC | 550,000 | $5,935,000 | 1.75% |
| Frazier Life Sciences Management, L.P. | 2,159,154 | $23,297,272 | 1.69% |
| HighVista Strategies LLC | 183,984 | $1,985,187 | 1.62% |